πŸ‡ΊπŸ‡Έ FDA
Patent

US 10260101

C-kit oncogene mutations in melanoma

granted A61PA61P35/00

Quick answer

US patent 10260101 (C-kit oncogene mutations in melanoma) held by The Regents of the University of California expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P35/00